0000950123-21-014994.txt : 20211112
0000950123-21-014994.hdr.sgml : 20211112
20211112164447
ACCESSION NUMBER: 0000950123-21-014994
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210930
FILED AS OF DATE: 20211112
DATE AS OF CHANGE: 20211112
EFFECTIVENESS DATE: 20211112
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vida Ventures Advisors, LLC
CENTRAL INDEX KEY: 0001831423
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20380
FILM NUMBER: 211404363
BUSINESS ADDRESS:
STREET 1: 40 BROAD STREET
STREET 2: SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 6176489100
MAIL ADDRESS:
STREET 1: 40 BROAD STREET
STREET 2: SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001831423
XXXXXXXX
09-30-2021
09-30-2021
false
Vida Ventures Advisors, LLC
40 Broad Street
Suite 201
Boston
MA
02109
13F HOLDINGS REPORT
028-20380
N
Jean-Philippe Kouakou-Zebouah
Chief Financial Officer
857-254-9492
/s/ Jean-Philippe Kouakou-Zebouah
Boston
MA
11-12-2021
0
8
349152
false
INFORMATION TABLE
2
7100.xml
INFORMATION TABLE FOR FORM 13F
Allogene Therapeutics, Inc.
Common Stock
019770106
46213
1798163
SH
SOLE
1798163
0
0
Centessa Pharmaceuticals plc
Ordinary Shares
152309100
65661
3931818
SH
SOLE
3931818
0
0
Dyne Therapeutics, Inc.
Common Stock
26818M108
48071
2960046
SH
SOLE
2960046
0
0
Homology Medicines, Inc.
Common Stock
438083107
6067
770845
SH
SOLE
770845
0
0
Kinnate Biopharma, Inc.
Common Stock
49705R105
63246
2747433
SH
SOLE
2747433
0
0
Kronos Bio, Inc.
Common Stock
50107A104
57961
2765314
SH
SOLE
2765314
0
0
Oyster Point Pharma, Inc.
Common Stock
69242L106
7585
640070
SH
SOLE
640070
0
0
Praxis Precision Medicines, Inc.
Common Stock
74006W108
54348
2939329
SH
SOLE
2939329
0
0